Integral Health Asset Management, LLC Sage Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

$850 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $3.42 Million - $4.45 Million	200,000 New	200,000 $4.33 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $6.71 Million - $9.82 Million	-165,000 Reduced 67.35%	80,000 $3.76 Million
Q1 2023 May 09, 2023	SELL	$37.27 - $46.57 $4.29 Million - $5.36 Million	-115,000 Reduced 31.94%	245,000 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $96,600 - $130,830	3,000 Added 0.84%	360,000 $13.7 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $1.78 Million - $2.39 Million	-55,257 Reduced 13.4%	357,000 $14 Million
Q2 2022 Aug 03, 2022	BUY	$27.52 - $37.99 $2.79 Million - $3.85 Million	101,257 Added 32.56%	412,257 $13.3 Million
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $3.01 Million - $4.48 Million	-98,000 Reduced 23.96%	311,000 $10.3 Million
Q4 2021 Feb 02, 2022	BUY	$37.06 - $47.11 $3.34 Million - $4.24 Million	90,000 Added 28.21%	409,000 $17.4 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $3.82 Million - $5.45 Million	95,000 Added 42.41%	319,000 $14.1 Million
Q2 2021 Aug 30, 2021	SELL	$54.88 - $79.29 $12.3 Million - $17.8 Million	-224,000 Reduced 50.0%	224,000 $12.7 Million
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $16.7 Million - $24.1 Million	304,000 Added 211.11%	448,000 $25.5 Million
Q1 2021 May 10, 2021	SELL	$70.65 - $96.76 $3.6 Million - $4.93 Million	-51,000 Reduced 26.15%	144,000 $10.8 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $2.04 Million - $3.12 Million	-35,000 Reduced 15.22%	195,000 $16.9 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $1.44 Million - $2.19 Million	35,000 Added 17.95%	230,000 $14.1 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $648,750 - $1.08 Million	25,000 Added 14.71%	195,000 $8.11 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $1.31 Million - $3.86 Million	50,000 Added 41.67%	170,000 $4.88 Million
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $7.22 Million - $18.6 Million	120,000 New	120,000 $8.66 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account